Generate a tailored SOP for Dr. Iman Azimi. Improve your application with a focused, well-structured draft.
Iman Azimi received his PhD in 2011 from the University of New South Wales, Sydney. He then joined the University of Queensland (UQ) as a postdoctoral fellow, where from 2011 to 2017 he worked on various projects in basic science with industry applications. His research primarily focuses on cancer hypoxia, metastatic processes, epithelial-mesenchymal transition (EMT), the tumor microenvironment, calcium signaling, and the development of high-throughput screening assays. In 2018, he became a Lecturer in Pharmaceutical Science at the University of Tasmania, where he established an independent research group within the College of Health and Medicine, receiving support from the Cancer Council Tasmania and other funding bodies. In 2023, Iman joined Monash University as a Senior Lecturer and Head of the Pharmacology Research Group at the Monash Biomedicine Discovery Institute. His leadership experience includes serving as Chair of the Institutional Biosafety Committee at Novotech CRO and member of various advisory and research committees. Iman's ongoing research includes investigating therapeutic targets for brain cancer, as well as understanding cellular aging and calcium signaling pathways in various diseases, aiming to enhance therapeutic interventions.
Monash University • Melbourne
Head of the Pharmacology Research Group at Monash Biomedicine Discovery Institute.
University of Tasmania • Hobart
Established an independent research group within the College of Health and Medicine.
University of Queensland • Brisbane
Worked on various projects in basic science and industry applications.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.